Ignite Creation Date:
2024-05-06 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03619811
Status:
COMPLETED
Last Update Posted:
2021-09-20
First Post:
2018-07-19
Brief Title:
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease
Sponsor:
University of California San Diego
Organization:
University of California San Diego
Study Overview
Official Title:
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease
Status:
COMPLETED
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study plans to learn more about reflux associated laryngeal symptoms and more efficient ways to diagnose and treat this condition
Detailed Description:
Reflux associated laryngeal symptoms coined laryngopharyngeal reflux occurs when gastro-esophago-pharyngeal reflux contributes to chronic laryngeal symptoms such as throat clearing sore throat and dysphonia Over the past 25 years Reflux associated laryngeal symptoms has been increasingly and often incorrectly diagnosed and has emerged as a point of controversy and confusion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None